Aalborg Psychiatric Hospital, Aarhus University Hospital, Denmark.
Acta Psychiatr Scand. 2010 May;121(5):385-8. doi: 10.1111/j.1600-0447.2009.01534.x. Epub 2010 Jan 19.
Recent research suggests that other surrogate markers than QTc, including QTc dispersion and Tpeak-Tend, may better correlate with cardiac arrhythmia risk. While sertindole significantly prolongs the QTc interval, the effects on other markers of arrhythmia risk, such as QTc dispersion and Tpeak-Tend are unknown.
Digital 12-lead ECG was recorded at baseline and at steady-state in 37 patients switched to sertindole. ECG was analysed for Fridericia-corrected QT duration (QTcF), QT dispersion and Tpeak-Tend.
From a baseline QTcF of 407 +/- 22 ms, mean QTcF prolongation during sertindole treatment was 20 +/- 23 ms, P < 0.01. No effect on QTc dispersion was found (-1 +/- 11 ms; P = 0.41). No increased duration of the Tpeak-Tend interval from baseline was found (+7 +/- 21 ms; P = 0.05).
These findings might be related to the absence of confirmed Torsade de Pointes (TdP) cases related to sertindole exposure, despite sertindole's QTc prolonging effects.
最近的研究表明,除 QTc 以外的其他替代标志物,包括 QTc 离散度和 Tpeak-Tend,可能与心律失常风险更好地相关。虽然舍吲哚显著延长 QTc 间期,但对心律失常风险的其他标志物(如 QTc 离散度和 Tpeak-Tend)的影响尚不清楚。
37 例转换为舍吲哚的患者在基线和稳态时记录数字 12 导联心电图。对 Fridericia 校正 QT 持续时间(QTcF)、QT 离散度和 Tpeak-Tend 进行心电图分析。
舍吲哚治疗期间,从基线 QTcF 的 407 +/- 22 ms 开始,平均 QTcF 延长 20 +/- 23 ms,P < 0.01。未发现 QTc 离散度的影响(-1 +/- 11 ms;P = 0.41)。与基线相比,Tpeak-Tend 间隔的持续时间没有增加(+7 +/- 21 ms;P = 0.05)。
尽管舍吲哚具有延长 QTc 的作用,但这些发现可能与舍吲哚暴露后没有确认与 Torsade de Pointes(TdP)相关的案例有关。